Immunotherapy draws the lion’s share of attention from top VCs, but startups focused on other types of cancer therapies, such as protein targeting, are also starting to gain recognition.
{iframe}https://www.cbinsights.com/research/top-venture-capital-firms-cancer-startups/?utm_source=CB+Insights+Newsletter&utm_campaign=3a86e452ba-Top_Research_Briefs_12_16_2017&utm_medium=email&utm_term=0_9dc0513989-3a86e452ba-86032085{/iframe}